Bristol-Myers Squibb Co.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.78B | $19.43B | $16.56B | $15.88B | $16.39B | $17.62B | $21.24B | $19.48B |
| United States | $11.51B | $10.77B | $8.59B | $7.64B | $7.54B | $9.46B | $11.81B | $11.35B |
| International | $9.26B | $8.66B | $7.97B | $8.24B | $8.85B | $8.16B | $9.43B | $8.13B |
| Cost of Revenue | $6.01B | $4.97B | $3.91B | $3.93B | $4.62B | $4.61B | $5.60B | $5.28B |
| Gross Profit | $14.68B | $14.48B | $12.65B | $11.95B | $11.77B | $13.01B | $15.65B | $14.21B |
| Gross Margin | 70.7% | 74.5% | 76.4% | 75.2% | 71.8% | 73.8% | 73.6% | 72.9% |
| Operating Expenses | ||||||||
| Research & Development | $6.47B | $5.01B | $5.92B | $4.53B | $3.73B | $3.90B | $3.84B | $3.57B |
| SG&A Expense | $4.75B | $4.98B | $4.84B | $4.82B | $4.94B | $4.22B | $4.20B | $3.69B |
| Operating Income | $5.33B | $6.08B | $2.26B | $2.58B | $3.09B | $2.52B | $7.13B | $6.22B |
| Operating Margin | 25.6% | 31.3% | 13.7% | 16.3% | 18.9% | 14.3% | 33.5% | 31.9% |
| Interest Expense | $196.0M | $167.0M | $184.0M | $203.0M | $199.0M | $182.0M | $145.0M | $145.0M |
| Pretax Income | $5.13B | $5.92B | $2.08B | $2.38B | $2.89B | $2.34B | $6.98B | $6.07B |
| Income Tax Expense | $4.16B | $1.41B | $446.0M | $352.0M | $311.0M | $-161.0M | $1.72B | $1.56B |
| Net Income | $1.01B | $4.46B | $1.57B | $2.00B | $2.56B | $1.96B | $3.71B | $3.10B |
| Net Margin | 4.8% | 22.9% | 9.5% | 12.6% | 15.6% | 11.1% | 17.5% | 15.9% |
| EPS (Basic) | $0.61 | $2.67 | $0.94 | $1.21 | $1.56 | $1.17 | $2.18 | $1.80 |
| EPS (Diluted) | $0.61 | $2.65 | $0.93 | $1.20 | $1.54 | $1.16 | $2.16 | $1.79 |
| Shares Outstanding (Basic) | 1.65B | 1.67B | 1.67B | 1.66B | 1.64B | 1.67B | 1.70B | 1.71B |
| Shares Outstanding (Diluted) | 1.65B | 1.68B | 1.68B | 1.67B | 1.66B | 1.69B | 1.72B | 1.73B |
| Dividends Per Share | $1.57 | $1.53 | $1.49 | $1.45 | $1.41 | $1.37 | $1.33 | $1.29 |